A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Novartis, New York

Novartis, New York

Novartis, New York

Novartis, Philadelphia

Novartis, Washington D.C.

Novartis, Baltimore

Novartis, Charlottesville

Novartis, Winston-Salem

Novartis, Durham

Novartis, Greenville

Novartis, Charlotte

Novartis, Orlando

Novartis, Nashville

Novartis, Cleveland

Novarits, Detroit

Novarits, Fargo

Novartis, New Orleans

Novartis, Dallas

Novartis, Temple

Novartis, Houston

Novartis, Aurora

Novartis, Murray

Novartis, Phoenix

Novartis, Los Angeles

Novartis, Los Angeles

Novartis, Los Angeles

Novartis, San Diego

Novartis, Orange

Novartis, San Francisco

Novartis, Portland

Novartis, Portland

Novartis, Portland

Novartis, Boston

Novartis, Boston

Novartis, Springfield

Novartis, Providence

Novartis, Burlington